JPML reports 15,264 pending actions in MDL-2873 on October 1, 2026, unchanged from 15,264 on September 1; 19,840 total historical actions are reported separately.
Official sourceJPML reports 8,424 pending actions in MDL-2666 on October 1, 2026, down 9 from 8,433 on September 1; 10,828 total historical actions are reported separately.
Official sourceJPML reports 23,324 pending actions in MDL-2846 on October 1, 2026, up 8 from 23,316 on September 1; 25,217 total historical actions are reported separately.
Official sourceJPML reports 4,140 pending actions in MDL-3081 on October 1, 2026, up 406 from 3,734 on September 1; 4,420 total historical actions are reported separately.
Official sourceJPML reports 6,470 pending actions in MDL-2570 on October 1, 2026, down 31 from 6,501 on September 1; 11,478 total historical actions are reported separately.
Official sourceJPML reports 6,412 pending actions in MDL-3140 on October 1, 2026, up 9 from 6,403 on September 1; 6,524 total historical actions are reported separately.
Official sourceSeptember 4 orders appoint a supplemental compensation fund allocation master (CMO 15), a qualified settlement fund administrator (CMO 16) and a lien resolution master (CMO 17). The orders page reviewed October 11 shows no Rule 702 ruling and lists a December 18 case management conference.
Official sourceJPML reports 1,838 pending actions in MDL-3044 on October 1, 2026, unchanged from 1,838 on September 1; 1,847 total historical actions are reported separately.
Official sourceJPML reports 12,381 pending actions in MDL-3060 on October 1, 2026, up 252 from 12,129 on September 1; 16,828 total historical actions are reported separately.
Official sourceJPML reports 69,340 pending actions in MDL-2738 on October 1, 2026, up 90 from 69,250 on September 1; 72,024 total historical actions are reported separately.
Official sourceJPML reports 844 pending actions in MDL-3026 on October 1, 2026, down 3 from 847 on September 1; 1,064 total historical actions are reported separately.
Official sourceAn October 8 scheduling order sets closing arguments on the pending Rule 702 motions for Cross Cutting Issues 2 and 3 for October 13, 2026. The public orders page reviewed October 11 shows no Rule 702 ruling, bellwether trial date or settlement program.
Official sourceJPML reports 4,025 pending actions in MDL-3094 on October 1, 2026, up 3 from 4,022 on September 1; 4,139 total historical actions are reported separately.
Official sourceThe separate MDL-3163 has 247 pending actions as of October 1, 2026, compared with 216 on September 1.
Official sourceJPML reports 4,224 pending actions in MDL-2974 on October 1, 2026, up 39 from 4,185 on September 1; 4,552 total historical actions are reported separately.
Official sourceJPML reports 6,602 pending actions in MDL-3004 on October 1, 2026, down 64 from 6,666 on September 1; 8,495 total historical actions are reported separately.
Official sourceJPML reports 1,104 pending actions in MDL-2741 on October 1, 2026, down 2,821 from 3,925 on September 1; 5,324 total historical actions are reported separately.
Official sourceThe settlement administrator's FAQ, checked October 11, still says the court will decide whether to approve the King v. Monsanto settlement after the September 14 fairness hearing, with timing unknown.
Official sourceA St. Louis state-court trial for three non-Hodgkin lymphoma plaintiffs outside the class settlement opened September 29, 2026, on design-defect and inadequate-testing theories. Monsanto disputes the claims.
Official sourceJPML reports 3,824 pending actions in MDL-3047 on October 1, 2026, up 616 from 3,208 on September 1; 4,009 total historical actions are reported separately.
Official sourceJPML reports 2,022 pending actions in MDL-3092 on October 1, 2026, up 195 from 1,827 on September 1; 2,112 total historical actions are reported separately.
Official source